Carisma Therapeutics Inc. (CARM)
NASDAQ: CARM
· Real-Time Price · USD
0.45
-0.05 (-10.41%)
At close: Jun 20, 2025, 3:59 PM
Carisma Therapeutics Revenue
Carisma Therapeutics reported an annual revenue of $19.63M, reflecting a 31.59% growth. For the quarter ending March 31, 2025, Carisma Therapeutics generated $3.73M in revenue.
Revenue (ttm)
19.63M
Revenue Growth
31.59%
Price / Sales Ratio
0.88
Revenue / Employee
426.78K
Employees
46
Market Cap
18.75M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 19.63M | +31.59% |
| Dec 31, 2023 | 14.92M | +51.71% |
| Dec 31, 2022 | 9.83M | -62.95% |
| Dec 31, 2021 | 26.54M | +136.24% |
| Dec 31, 2020 | 11.24M | n/a |